These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17372240)

  • 1. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause.
    Verheus M; Peeters PH; Kaaks R; van Noord PA; Grobbee DE; van Gils CH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):451-7. PubMed ID: 17372240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
    Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
    Verheus M; McKay JD; Kaaks R; Canzian F; Biessy C; Johansson M; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2008 Nov; 112(1):109-22. PubMed ID: 18064566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
    Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
    Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
    Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
    Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone.
    Mulhall C; Hegele RA; Cao H; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2648-54. PubMed ID: 16284391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
    Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
    dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.